Last reviewed · How we verify

NCT06851416: CALCULATE

Cross-Cultural Adaptation on CALCULATE in a Critical Care Unit

Completed Last updated 28 February 2025
What this trial tests

trial in Pressure Injury in 86 participants. Completed in 31 December 2024.

Timeline
1 September 2024
Primary endpoint
1 November 2024
31 December 2024

Quick facts

Lead sponsorIstanbul University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment86
Start date1 September 2024
Primary completion1 November 2024
Estimated completion31 December 2024
Sites1 location across Turkey (Türkiye)

Conditions studied

Sponsor

Istanbul University

Who can join

18 and older, any sex, with Pressure Injury or Critical Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Pressure injuries are localized lesions that occur in the skin and/or underlying tissues due to pressure, or pressure in combination with shear. PIs arise as a consequence of prolonged immobility during hospitalization, leading to increased morbidity, mortality, prolonged hospital stays which may result in higher healthcare costs. Critically ill patients are vulnerable cohort of patients at a higher risk of developing PIs compared to the general population due to factors such as immobility, severity of illness, hemodynamic instability, ventilation, use of vasopressors, and the application of medical devices.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Pressure Injury

Currently open trials in the same condition.

Other Istanbul University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06851416.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing